UPS helps big pharma: Vaccines made ‘easy’ for all adults in their home

Print Friendly, PDF & Email

 

ups-delivery(NaturalHealth365) Big Pharma and big government will celebrate the latest news about vaccines.  UPS (United Parcel Service) and pharmaceutical conglomerates will likely tout it as a progressive innovation that aims to protect adults and improve public health through such faulty logic as “herd immunity.”

What is this news exactly?  In short, it’s a new pilot vaccination project between UPS and vaccine manufacturer Merck. The pilot intends to ship vaccines all over the country and have them administered by “professionals” within your very own home.

Concerned about vaccines?  ‘Don’t worry’ says big pharma and UPS, as they roll out plans to make it easier to get vaccinated – but, at what cost?

These days, the world’s largest package delivery service seems all too willing to push their nose into the American people’s private lives and medical decision-making.

According to an article recently published by major news outlet Reuters, “UPS is targeting a larger slice of the $85 billion outsourced healthcare logistics market.”  By outsourced, this means “home delivery” health – aka taking the vaccination propaganda on the road.

In other words, UPS will be teaming up with major pharmaceutical powerhouses to get vaccines delivered straight to a person’s very own house – no doubt with the ultimate goal of bringing vaccines past as many thresholds as possible in America.

Do NOT ignore the health dangers linked to toxic indoor air.  These chemicals - the 'off-gassing' of paints, mattresses, carpets and other home/office building materials - increase your risk of headaches, dementia, heart disease and cancer.

Get the BEST indoor air purification system - at the LOWEST price, exclusively for NaturalHealth365 readers.  I, personally use this system in my home AND office.  Click HERE to order now - before the sale ends.

How is this supposed to work, you may ask? Again from Reuters: “[UPS employees] will package and ship the vaccine to one of the more 4,700 franchised U.S. UPS stores. A home health nurse contracted by UPS’ clinical trial logistics unit known as Marken will collect the insulated package, transport it the ‘last mile’ to the patient’s home and administer the vaccine, which will target a viral illness in adults.”

As for which vaccines will be pushed on the public in this “door-to-door” vaccination initiative, mum’s the word.  Either way, this pilot project just screams shady to us. Are we supposed to believe that they’re not going to try to expand this project – to more households and to minors, too?

And how exactly do they plan on vouching for the training and safety of these so-called “professionals” who will be entering strangers homes and injecting these drugs?  What are their contingency plans for when things inevitably go wrong – including theft and serious adverse vaccine reactions – and how many US adults will have to play the guinea pigs as they figure this out?

Perhaps most importantly, how will this project accelerate the current state of the U.S. vaccination program – which injures, disables, and kills adults and children every year in this country?

Sending drugs into homes, to be administered by complete strangers – we have to ask, who is actually benefiting from this?

Let us not forget that the pharmaceutical company Merck has a history of ethical digressions – like physician bribery and price fixing, to name just a few.  The fact that UPS has eagerly and gleefully teamed up with this organization says a lot about the true intent of this pilot program:

We’ll give you a hint: it’s all about the green paper.

UPS stands to profit immensely from this program. They almost can’t be blamed for scrambling to find ways to boost profits, given the current age we’re in of click-and-purchase from major rival Amazon.

We don’t know…for some reason, the term “mail order drug pushers” keeps popping into our minds. Sadly, we’re starting to think that’s not too harsh.

Sources for this article include:

Reuters.com
HHS.gov